In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Grifols divests some Talecris assets to Kedrion SPA

Executive Summary

To satisfy FTC merger conditions associated with its pending acquisition of Talecris Biotherapeutics Inc. (signed in 2010), Grifols SA has agreed to the sale of some of Talecris’s assets to Italian plasma production company Kedrion SPA.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Manufacturing or Supply
    • Product Purchase

Related Companies